Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease

Show other versions (1)

Introduction and Objective: Lipoprotein(a) [Lp(a)] is an independent cardiovascular risk factor but is closely associated with other similar risk factors that are manageable with appropriate treatment and guidance. We aimed to study the impact of using combined therapy for managing Lp(a) levels in p...

Full description

Bibliographic Details
Main Authors:	Joaquim A. Meireles Brandão, Lúcia R. Meireles-Brandão, Rui Coelho, Francisco Rocha-Gonçalves
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204919302302

Similar Items

Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease
by: Joaquim A. Meireles Brandão, et al.
Published: (2019-07-01)

Lipoprotein(a) in the Evaluation of Cardiovascular Risk in the Portuguese Population
by: Joaquim A. Meireles-Brandão, et al.
Published: (2019-03-01)

High-density lipoproteins: a novel therapeutic target for cardiovascular disease
by: TS Mohamed Saleem, et al.
Published: (2011-01-01)

Lipoproteina (a) e risco vascular
by: Joaquim António Meireles Brandão
Published: (2021)

Lipoprotein(a) as a novel therapeutic target for preventing cardiovascular disease: A whiter shade of pale?
by: Manuela Fiuza
Published: (2019-07-01)

Lipoprotein(a) as a novel therapeutic target for preventing cardiovascular disease: A whiter shade of pale?
by: Manuela Fiuza
Published: (2019-07-01)

Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges
by: Yin Tintut, et al.
Published: (2018-11-01)

Lipoprotein(a) in Cardiovascular Diseases
by: Michele Malaguarnera, et al.
Published: (2013-01-01)

Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders
by: Daniel P. Jones, et al.
Published: (2018-11-01)

Lipoprotein Nanoplatform for Targeted Delivery of Diagnostic and Therapeutic Agents
by: Jerry D. Glickson, et al.
Published: (2008-03-01)

Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease
by: Jiayi Yin, et al.
Published: (2021-01-01)

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
by: Navin K Kapur, et al.
Published: (2008-02-01)

Modern Approaches to Lower Lipoprotein(a) Concentrations and Consequences for Cardiovascular Diseases
by: Victoria A. Korneva, et al.
Published: (2021-09-01)

HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE
by: Stephen J. Nicholls, et al.
Published: (2020-10-01)

Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases
by: Takashi Obama, et al.
Published: (2020-11-01)

Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease
by: Gary A. Cuthbert, et al.
Published: (2020-11-01)

Iron Deficiency as a Therapeutic Target in Cardiovascular Disease
by: Samira Lakhal-Littleton
Published: (2019-08-01)

Endothelial Progenitor Cells: Therapeutic Target for Cardiovascular Diseases
by: Takashi Umemura, et al.
Published: (2008-01-01)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
by: Philip J. Barter
Published: (2013-09-01)

Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?
by: Martin B Whyte
Published: (2019-08-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
by: Lucia Recinella, et al.
Published: (2020-10-01)

Molecular target based combinational therapeutic approaches in thyroid cancer
by: Rajoria Shilpi, et al.
Published: (2012-05-01)

Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease
by: Sam L. Stephen, et al.
Published: (2010-01-01)

Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
by: Thomas Senoner, et al.
Published: (2019-09-01)

Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
by: Liang-Yin Ke, et al.
Published: (2020-11-01)

THE ROLE OF LIPOPROTEIN(A) IN CARDIOVASCULAR DISEASES IN CHILDREN AND ADOLESCENTS
by: Alina-Costina LUCA, et al.
Published: (2016-07-01)

PCSK9: A Key Target for the Treatment of Cardiovascular Disease (CVD)
by: Saeideh Sobati, et al.
Published: (2020-08-01)

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
by: Manfredi Rizzo, et al.
Published: (2013-03-01)

Oxidized low‐density lipoproteins as a novel risk factor and therapeutic target for ACM
by: Hoyee Tsui, et al.
Published: (2021-09-01)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
by: Jairo Lumpuy-Castillo, et al.
Published: (2020-09-01)

Roles and mechanisms of renalase in cardiovascular disease: A promising therapeutic target
by: Yue Li, et al.
Published: (2020-11-01)

Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?
by: Ning Yang, et al.
Published: (2015-01-01)

The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets
by: Siarhei A. Dabravolski, et al.
Published: (2021-08-01)

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
by: Janice V. Huang, et al.
Published: (2012-09-01)

Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration
by: Alexander Lin, et al.
Published: (2021-03-01)

Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
by: Susana Coimbra, et al.
Published: (2021-05-01)

Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020-03-01)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
by: Groenhof, T Katrien J, et al.
Published: (2020-04-01)

Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies
by: Maria Teresa Valenti, et al.
Published: (2021-03-01)